Vertex Pharmaceuticals Inc / Ma

KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

11,645

Value ($000)

5,280

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	5,280	0.0%	11,645	12/31/2025
2025 Q3	11/13/2025	4,551	0.0%	11,619	9/30/2025
2025 Q2	8/13/2025	5,348	0.0%	12,013	6/30/2025
2025 Q1	5/14/2025	5,931	0.0%	12,234	3/31/2025
2024 Q4	2/21/2025	4,943	0.0%	12,274	12/31/2024
2024 Q3	11/13/2024	6,093	0.0%	13,101	9/30/2024
2024 Q2	8/13/2024	6,293	0.0%	13,426	6/30/2024
2024 Q1	5/14/2024	5,735	0.0%	13,719	3/31/2024
2023 Q4	2/13/2024	5,779	0.0%	14,202	12/31/2023
2023 Q3	11/13/2023	5,134	0.0%	14,763	9/30/2023
2023 Q2	8/11/2023	5,234	0.0%	14,874	6/30/2023
2023 Q1	5/16/2023	4,757	0.0%	15,097	3/31/2023
2022 Q4	2/14/2023	4,359	0.0%	15,093	12/31/2022
2022 Q3	11/16/2022	4,555	0.0%	15,732	9/30/2022
2022 Q2	8/12/2022	3	0.0%	10	6/30/2022
2022 Q1	5/16/2022	9	0.0%	36	3/31/2022
2021 Q4	2/14/2022	2	0.0%	10	12/31/2021
2021 Q3	11/12/2021	2	0.0%	10	9/30/2021
2021 Q2	8/13/2021	2	0.0%	10	6/30/2021
2021 Q1	5/17/2021	2	0.0%	10	3/31/2021
2020 Q4	2/12/2021	2	0.0%	10	12/31/2020
2020 Q3	11/16/2020	3	0.0%	10	9/30/2020
2020 Q2	8/14/2020	8	0.0%	27	6/30/2020
2020 Q1	5/15/2020	6	0.0%	27	3/31/2020
2019 Q4	2/13/2020	6	0.0%	27	12/31/2019